HRSA-Initiated Supplemental Funding to U13 Grant Program Award Recipient

Riepilogo

HRSA is providing approximately $4,900,000 in supplemental funding to the University of Kansas, Medical Center Research Institute, Inc. (U13HS33878), the sole award recipient under the Reimbursement of Travel and Subsistence Expenses toward Living Organ Donation Program, to provide increased financial support to living organ donors during the period of September 1, 2020, to August 31, 2021.